- Home
- ACLX vs EQX Comparison
ACLX vs EQX Comparison
Compare ACLX & EQX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACLX
- EQX
- Stock Information
- Founded
- ACLX 2015
- EQX 2007
- Country
- ACLX United States
- EQX Canada
- Employees
- ACLX N/A
- EQX N/A
- Industry
- ACLX Biotechnology: Pharmaceutical Preparations
- EQX Precious Metals
- Sector
- ACLX Health Care
- EQX Basic Materials
- Exchange
- ACLX Nasdaq
- EQX Nasdaq
- Market Cap
- ACLX 3.3B
- EQX 2.7B
- IPO Year
- ACLX 2022
- EQX N/A
- Fundamental
- Price
- ACLX $67.96
- EQX $6.88
- Analyst Decision
- ACLX Strong Buy
- EQX
- Analyst Count
- ACLX 13
- EQX 0
- Target Price
- ACLX $110.82
- EQX N/A
- AVG Volume (30 Days)
- ACLX 617.2K
- EQX 9.6M
- Earning Date
- ACLX 05-08-2025
- EQX 05-07-2025
- Dividend Yield
- ACLX N/A
- EQX N/A
- EPS Growth
- ACLX N/A
- EQX 738.78
- EPS
- ACLX N/A
- EQX 0.75
- Revenue
- ACLX $107,936,000.00
- EQX $1,514,120,000.00
- Revenue This Year
- ACLX N/A
- EQX $51.11
- Revenue Next Year
- ACLX $103.84
- EQX $16.04
- P/E Ratio
- ACLX N/A
- EQX $9.10
- Revenue Growth
- ACLX N/A
- EQX 39.14
- 52 Week Low
- ACLX $47.88
- EQX $4.48
- 52 Week High
- ACLX $107.37
- EQX $7.24
- Technical
- Relative Strength Index (RSI)
- ACLX 47.21
- EQX 53.31
- Support Level
- ACLX $68.56
- EQX $6.82
- Resistance Level
- ACLX $72.68
- EQX $7.08
- Average True Range (ATR)
- ACLX 3.01
- EQX 0.23
- MACD
- ACLX -0.31
- EQX 0.00
- Stochastic Oscillator
- ACLX 18.14
- EQX 58.52
About ACLX Arcellx Inc.
Arcellx Inc is a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases.
About EQX Equinox Gold Corp.
Equinox Gold Corp is a mining company engaged in the operation, acquisition, exploration and development of mineral properties, with a focus on gold. Equinox Gold has around seven operating gold mines and a clear plan to increase production by advancing pipeline of growth projects.